Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

BACKGROUND: Although tolvaptan treatment improves hyponatremia, only few studies have investigated whether tolvaptan actually benefits the survival of cirrhotic patients. This study evaluated the impact of tolvaptan on six-month survival of decompensated cirrhotic patients with and without hyponatre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuzhen, Zhang, Xin, Han, Tao, Xie, Wen, Li, Yonggang, Ma, Hong, Liebe, Roman, Weng, Honglei, Ding, Hui-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123923/
https://www.ncbi.nlm.nih.gov/pubmed/30180806
http://dx.doi.org/10.1186/s12876-018-0857-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123923/
https://www.ncbi.nlm.nih.gov/pubmed/30180806
http://dx.doi.org/10.1186/s12876-018-0857-0

Ejemplares similares